U.S. Patent Disclosures
Monday, October 17, 2011
Cortex Pharmaceuticals Inc., of Irvine, Calif., received a notice of allowance for a patent protecting the use of Ampakine molecules for treating or preventing respiratory depression.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.